• Peripheral pachymetry reading < 560 µm (measured at the 6 mm optical zone)

• Strabismus surgery or are likely to develop strabismus following the Conductive Keratoplasty procedure

• Anterior segment pathology, including a cataract, in the eye to be treated

• Any corneal abnormality, such as recurrent corneal erosion or severe basement membrane disease, in the eye to be treated

• Ophthalmoscopic signs of progressive or unstable hyperopia in the eye to be treated

• Distorted or unclear central keratometry corneal mires in the eye to be treated

• Blindness in the fellow eye(one eyed patient)

• Previous intraocular or corneal surgery, including any refractive or therapeutic surgery, in the eye to be treated

• History of herpes zoster or herpes simplex keratitis

• History of steroid-responsive rise in intraocular pressure, glaucoma, or have a preoperative IOP >21 mm Hg

• Risks for angle-closure or have a potentially occludable angle

• Diabetes, diagnosed autoimmune disease, connective tissue disease or clinically significant atopic syndrome

• Current treatment with chronic systemic corticosteroid or other immunosuppressive therapy that may affect wound healing, and any immunocompromised patients

• Using ophthalmic medications, other than artificial tears, for treatment of any ocular disease

• Using systemic medications with significant ocular side effects

• History of keloid fomation

• History or current case of intractable keratoconjunctivitis sicca

• Pregnant, lactating or plan to become pregnant